Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07228234 · ClinicalTrials.gov registry record · NA
Evaluating Mammography Communication Approaches
A NA study of The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 1,900
- Enrollment target
- 1
- Study location
NCT07228234: Recruiting NA study of The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence, sponsored by University of Colorado, Denver.
NCT07228234 is a NA study of The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 1,900 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07228234, a NA study of The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,900 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized online experiment testing different methods for communicating about the benefits and harms of breast cancer screening. Participants will be randomly assigned to experimental conditions which vary whether screening outcomes are referred to as "benefits and harms" vs. "outcomes that can happen with screening", and vary the presence or absence of information about improvements in breast cancer survivability. In a control condition, participants receive basic information about what mammography is (which is also information received in all other conditions). Primary outcomes include skepticism toward the information presented, and screening intentions.
Primary Outcome
Skepticism toward the screening message is assessed using the RED scale, consisting of 11 questions each measured on a 7-point Likert scale
Conditions Studied
Interventions
- OTHER No intervention
- OTHER Harm/benefit language vs. outcomes that can happen
- OTHER Breast cancer survivability information
Study Locations (1)
Colorado
- University of Colorado Anschutz - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,900 participants |
| Start Date | 2025-11-06 |
| Est. Completion | 2027-11-30 |
| Phase | NA |
What NCT07228234 shows while recruiting
NCT07228234 is an interventional study that assigns participants to a tested intervention. Its 1,900 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher).
The record links to 1 condition, with The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence appearing as the primary indexed condition, and to 3 interventions - of which No intervention is the first listed.
NCT07228234 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07228234 about?
NCT07228234 is a clinical study titled "Evaluating Mammography Communication Approaches". This is a randomized online experiment testing different methods for communicating about the benefits and harms of breast cancer screening. Participants will be randomly assigned to experimental conditions which vary whether screening outcomes are referred to as "benefits and harms" vs. "outcomes th...
What is the current status of trial NCT07228234?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,900 participants. The study started on 2025-11-06. Estimated completion is 2027-11-30.
What conditions does trial NCT07228234 study?
This clinical trial studies the following conditions: The Focus of This Study is to Identify How Different Approaches to Mammography Communication Affect Skepticism Toward Mammography Evidence.
What interventions are being tested in trial NCT07228234?
The interventions under investigation include: No intervention (OTHER), Harm/benefit language vs. outcomes that can happen (OTHER), Breast cancer survivability information (OTHER).
Who is sponsoring clinical trial NCT07228234?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07228234 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07228234's enrollment target sits among peer trials
1,900 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- NCT07280065 · 1,900 participants · Phase 3
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI